Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Nuño

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|October 18, 2021
Censoring-robust time-dependent receiver operating characteristic curve estimatorsMichelle M Nuño, Daniel L Gillen
Statistics in Medicine|October 26, 2020
Robust estimation in the nested case-control design under a misspecified covariate functional formMichelle M Nuño, Daniel L Gillen
Alzheimer Disease and Associated Disorders|April 9, 2019
Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?Joshua D Grill, Michelle M Nuño, Daniel L Gillen, et al.
Alzheimer'S Research & Therapy|November 29, 2019
Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trialsMichelle M Nuño, Daniel L Gillen, Joshua D Grill, et al.
Clinical Trials (London, England)|July 30, 2021
On the design of early-phase Alzheimer's disease clinical trials with cerebrospinal fluid tau outcomesMichelle M Nuño, Joshua D Grill, Daniel L Gillen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Impacts of informant replacement in two industry-sponsored Alzheimer's disease clinical trialsMikaela K Nishida, Michelle M Nuño, Joshua D Grill, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 14, 2023
Effects of informant replacement in Alzheimer's disease clinical trialsMikaela K Nishida, Michelle M Nuño, Joshua D Grill, et al.
European Urology Focus|May 10, 2022
Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative ReviewChristian D Fankhauser, Michelle M Nuño, Matthew J Murray, et al.
Pediatric Blood & Cancer|March 18, 2025
Standard-Dose Versus High-Dose Cisplatin for Intermediate/Poor-Risk Extracranial Malignant Germ Cell Tumors: Re-Analysis of Pediatric Oncology Group 9049 and Children's Cancer Group 8882 Trial Using Updated MaGIC Risk StratificationDaniel Prior, Jingye Yang, Michelle M Nuño, et al.
Journal of Alzheimer'S Disease : JAD|October 17, 2022
Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease TrialsMarina Ritchie, Megan Witbracht, Michelle M Nuño, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|October 18, 2021
Censoring-robust time-dependent receiver operating characteristic curve estimatorsMichelle M Nuño, Daniel L Gillen
Statistics in Medicine|October 26, 2020
Robust estimation in the nested case-control design under a misspecified covariate functional formMichelle M Nuño, Daniel L Gillen
Alzheimer Disease and Associated Disorders|April 9, 2019
Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?Joshua D Grill, Michelle M Nuño, Daniel L Gillen, et al.
Alzheimer'S Research & Therapy|November 29, 2019
Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trialsMichelle M Nuño, Daniel L Gillen, Joshua D Grill, et al.
Clinical Trials (London, England)|July 30, 2021
On the design of early-phase Alzheimer's disease clinical trials with cerebrospinal fluid tau outcomesMichelle M Nuño, Joshua D Grill, Daniel L Gillen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Impacts of informant replacement in two industry-sponsored Alzheimer's disease clinical trialsMikaela K Nishida, Michelle M Nuño, Joshua D Grill, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 14, 2023
Effects of informant replacement in Alzheimer's disease clinical trialsMikaela K Nishida, Michelle M Nuño, Joshua D Grill, et al.
European Urology Focus|May 10, 2022
Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative ReviewChristian D Fankhauser, Michelle M Nuño, Matthew J Murray, et al.
Pediatric Blood & Cancer|March 18, 2025
Standard-Dose Versus High-Dose Cisplatin for Intermediate/Poor-Risk Extracranial Malignant Germ Cell Tumors: Re-Analysis of Pediatric Oncology Group 9049 and Children's Cancer Group 8882 Trial Using Updated MaGIC Risk StratificationDaniel Prior, Jingye Yang, Michelle M Nuño, et al.
Journal of Alzheimer'S Disease : JAD|October 17, 2022
Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease TrialsMarina Ritchie, Megan Witbracht, Michelle M Nuño, et al.
Pageof 3